Skip to main content
NVDA+0.60%AAPL+0.39%GOOGL+0.93%MSFT+0.36%AMZN+0.32%TSM-0.16%SPCX+1.09%META+0.31%AVGO-1.10%TSLA+0.03%SKHY-1.36%MU+0.35%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%ABBV-0.65%1398.HK+0.78%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%PM-1.59%1288.HK+0.61%MS-2.43%GBPAUD+1.22%AUDUSD-1.08%GBPCHF+1.01%AUDJPY-0.98%USDCHF+0.85%GBPCAD+0.78%CHFJPY-0.69%EURGBP-0.67%USDCAD+0.65%GBPNZD+0.64%EURAUD+0.56%AUDNZD-0.56%USDTHB+0.54%EURUSD-0.54%NZDUSD-0.52%CADJPY-0.51%AUDCAD-0.46%EURJPY-0.42%GBPTRY+0.41%NZDJPY-0.38%NZDCHF+0.34%GBPHKD+0.32%EURCHF+0.31%USDTRY+0.29%GBPMXN-0.28%GBPJPY+0.27%AUDCHF-0.25%CADCHF+0.22%USDCNH-0.21%USDILS+0.16%GBPUSD+0.14%NZDCAD+0.12%USDJPY+0.12%EURCAD+0.11%AUDNOK+0.08%SGDJPY+0.05%USDMXN+0.04%AUDDKK+0.04%USDCOP-0.04%NZDMXN+0.04%USDHKD+0.03%AUDSGD+0.03%USDSGD-0.02%EURSGD-0.02%GBPSGD-0.02%EURHKD-0.02%EURCNH-0.01%USDDKK-0.01%NZDSGD-0.01%EURDKK0.00%EURNZD0.00%GBPZAR0.00%USDZAR0.00%CHFSGD0.00%CHFNOK0.00%EURZAR0.00%CHFSEK0.00%EURPLN0.00%EURSEK0.00%EURCZK0.00%PLNJPY0.00%USDNOK0.00%EURNOK0.00%USDSEK0.00%NOKJPY0.00%USDPLN0.00%USOIL-0.59%XPTUSD-0.40%XNGUSD+0.30%HG1-0.14%GAUUSD-0.03%XAUUSD-0.03%GAGUSD-0.03%XAGUSD-0.02%C10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.09%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.89%ZECUSDT+1.42%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.53%XLMUSD+2.19%BCHUSDT-0.51%UNIUSD+0.06%LTCUSD+0.07%HBARUSDT+2.56%SUIUSD+1.11%TONUSD+15.77%TAOUSDT+0.17%AAVEUSD-3.46%DOTUSDT+2.62%ICPUSDT-3.24%ONDOUSDT-0.30%WLDUSDT+9.69%ARBUSDT-0.26%JUPUSDT-0.20%ATOMUSDT+1.10%INJUSDT-2.52%STXUSDT+17.69%FETUSDT+2.53%SEIUSDT+0.33%PYTHUSDT-2.15%TIAUSDT+0.27%IMXUSDT+0.97%GRTUSDT+0.11%OPUSDT+0.54%WIFUSDT+3.46%IOTAUSDT+4.25%POLUSDT-3.40%AXSUSDT+0.93%FARTCOINUSDT-0.39%EOSUSDT+4.50%DYDXUSDT+3.80%GALAUSDT+4.75%ORDIUSDT+1.02%NOTUSDT+1.55%RONINUSDT+0.06%NVDA+0.60%AAPL+0.39%GOOGL+0.93%MSFT+0.36%AMZN+0.32%TSM-0.16%SPCX+1.09%META+0.31%AVGO-1.10%TSLA+0.03%SKHY-1.36%MU+0.35%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%ABBV-0.65%1398.HK+0.78%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%PM-1.59%1288.HK+0.61%MS-2.43%GBPAUD+1.22%AUDUSD-1.08%GBPCHF+1.01%AUDJPY-0.98%USDCHF+0.85%GBPCAD+0.78%CHFJPY-0.69%EURGBP-0.67%USDCAD+0.65%GBPNZD+0.64%EURAUD+0.56%AUDNZD-0.56%USDTHB+0.54%EURUSD-0.54%NZDUSD-0.52%CADJPY-0.51%AUDCAD-0.46%EURJPY-0.42%GBPTRY+0.41%NZDJPY-0.38%NZDCHF+0.34%GBPHKD+0.32%EURCHF+0.31%USDTRY+0.29%GBPMXN-0.28%GBPJPY+0.27%AUDCHF-0.25%CADCHF+0.22%USDCNH-0.21%USDILS+0.16%GBPUSD+0.14%NZDCAD+0.12%USDJPY+0.12%EURCAD+0.11%AUDNOK+0.08%SGDJPY+0.05%USDMXN+0.04%AUDDKK+0.04%USDCOP-0.04%NZDMXN+0.04%USDHKD+0.03%AUDSGD+0.03%USDSGD-0.02%EURSGD-0.02%GBPSGD-0.02%EURHKD-0.02%EURCNH-0.01%USDDKK-0.01%NZDSGD-0.01%EURDKK0.00%EURNZD0.00%GBPZAR0.00%USDZAR0.00%CHFSGD0.00%CHFNOK0.00%EURZAR0.00%CHFSEK0.00%EURPLN0.00%EURSEK0.00%EURCZK0.00%PLNJPY0.00%USDNOK0.00%EURNOK0.00%USDSEK0.00%NOKJPY0.00%USDPLN0.00%USOIL-0.59%XPTUSD-0.40%XNGUSD+0.30%HG1-0.14%GAUUSD-0.03%XAUUSD-0.03%GAGUSD-0.03%XAGUSD-0.02%C10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.09%ETHUSD+7.44%USDTUSD-0.02%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.89%ZECUSDT+1.42%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.53%XLMUSD+2.19%BCHUSDT-0.51%UNIUSD+0.06%LTCUSD+0.07%HBARUSDT+2.56%SUIUSD+1.11%TONUSD+15.77%TAOUSDT+0.17%AAVEUSD-3.46%DOTUSDT+2.62%ICPUSDT-3.24%ONDOUSDT-0.30%WLDUSDT+9.69%ARBUSDT-0.26%JUPUSDT-0.20%ATOMUSDT+1.10%INJUSDT-2.52%STXUSDT+17.69%FETUSDT+2.53%SEIUSDT+0.33%PYTHUSDT-2.15%TIAUSDT+0.27%IMXUSDT+0.97%GRTUSDT+0.11%OPUSDT+0.54%WIFUSDT+3.46%IOTAUSDT+4.25%POLUSDT-3.40%AXSUSDT+0.93%FARTCOINUSDT-0.39%EOSUSDT+4.50%DYDXUSDT+3.80%GALAUSDT+4.75%ORDIUSDT+1.02%NOTUSDT+1.55%RONINUSDT+0.06%
DE

DexCom, Inc. (DXCM)

NASDAQ • Healthcare

$86.29
-$0.34 (-0.4%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$86.21
Day Range$85.26 - $86.75
Avg. Volume (3M)4M
Market Cap$32.5B
P/E Ratio33.3
52 Week Range
$54.11$92.59
Next EarningsIn 29 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$1.3B100%
Gross Profitminus cost of goods$830M63%
Operating Incomeminus R&D and overhead$318.3M24%
Net Incomeminus taxes and the rest$249.1M19%

In plain terms: out of every $100 in revenue, DexCom, Inc. keeps $19 as net profit.

Fundamentals & Financials

Revenue (TTM)
$4.9B
Net Income (TTM)
$999.7M
EPS (TTM)
$2.59
ROA (TTM)
15.49%
Current Ratio
1.73

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+4.6%Q1 2026$0.68
+20.3%Q2 2026$0.56
+14.6%Q3 2026$0.7
Next

Oct 29

in 29 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +14.6%

DexCom beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 30, with adjusted EPS of $0.70 topping the $0.61 estimate (+15%) and revenue of $1.308 billion topping the $1.290 billion estimate (+1.4%). Revenue rose ~13% to about $1.3 billion (up from roughly $1.2 billion a year ago), while profitability was supported by a gross margin of ~63% and operating margin of ~24%. Gross profit came in around $830 million and operating income was roughly $318 million, and net income increased ~39% to about $249 million (up from nearly $180 million a year ago). On the bottom line, adjusted EPS was up ~46% from $0.48 a year ago. DexCom generated operating cash flow of roughly $269 million and repurchased about $604 million of stock during the quarter. For the next period, consensus calls for EPS of $0.66 on revenue of $1.328 billion.

Next report — what to expect

DexCom, Inc. (DXCM) reports earnings on October 29, 2026. Wall Street is expecting EPS of $0.671 on revenue of $1.33 billion. For trailing context, revenue grew +13.1% year over year last quarter. DXCM has beaten EPS in 6 of 8 most recent quarters, so comparisons to consensus will be a key focus.

View full earnings history

About DexCom, Inc.

DexCom, Inc. (NASDAQ: DXCM) makes glucose monitoring systems and related digital tools for diabetes care, operating in the medical technology sector. Its business spans continuous glucose monitoring hardware, data-sharing software, and application integrations sold in the United States and abroad, and it generated $4.7 billion of revenue in FY2025.

Name
DexCom, Inc.
CEO
Jacob Steven Leach
Industry
Healthcare
Year Founded
1999
Employees
11,050

Today's Snapshot

AI-generated

DXCM ended the day slightly lower at 86.29, while its sector was weaker.

Trading Volume

Below 10d avg (4.6M)

3.4M

vs S&P 500 Today

Underperforming Market

-0.59%

Updated: September 30, 2026 at 20:31 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
DXCM displays a muted, mixed setup with short-term averages trading slightly above the current price while medium and long-term averages remain firmly supportive, and on-balance volume is constructive. Momentum measures are tepid — RSI near the midpoint and a small positive MACD accompany a negative short-term momentum reading — and stochastic action is neutral, so momentum lacks conviction. Trend strength is limited with ADX below 20, and volatility is moderate with an ATR near two dollars. The pivot aligns with the market. Technical takeaway: Neutral.
All signals
  • EMA (5 indicators)$74.88 - $87.18
    Buy
  • RSI (14)47.40
    Neutral
  • Stochastic %K (14, 3, 3)51.22
    Neutral
  • MACD Level (12, 26)0.19
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.